Cargando…
Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection
To determine the mechanisms that mediate resistance to Mycobacterium tuberculosis (M. tuberculosis) infection in household contacts (HHCs) of patients with tuberculosis (TB), we followed 452 latent TB infection–negative (LTBI(–)) HHCs for 2 years. Those who remained LTBI(–) throughout the study were...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746823/ https://www.ncbi.nlm.nih.gov/pubmed/36509283 http://dx.doi.org/10.1172/jci.insight.152357 |
_version_ | 1784849449662545920 |
---|---|
author | Tripathi, Deepak Devalraju, Kamakshi Prudhula Neela, Venkata Sanjeev Kumar Mukherjee, Tanmoy Paidipally, Padmaja Radhakrishnan, Rajesh Kumar Dozmorov, Igor Vankayalapati, Abhinav Ansari, Mohammad Soheb Mallidi, Varalakshmi Bogam, Anvesh Kumar Singh, Karan P. Samten, Buka Valluri, Vijaya Lakshmi Vankayalapati, Ramakrishna |
author_facet | Tripathi, Deepak Devalraju, Kamakshi Prudhula Neela, Venkata Sanjeev Kumar Mukherjee, Tanmoy Paidipally, Padmaja Radhakrishnan, Rajesh Kumar Dozmorov, Igor Vankayalapati, Abhinav Ansari, Mohammad Soheb Mallidi, Varalakshmi Bogam, Anvesh Kumar Singh, Karan P. Samten, Buka Valluri, Vijaya Lakshmi Vankayalapati, Ramakrishna |
author_sort | Tripathi, Deepak |
collection | PubMed |
description | To determine the mechanisms that mediate resistance to Mycobacterium tuberculosis (M. tuberculosis) infection in household contacts (HHCs) of patients with tuberculosis (TB), we followed 452 latent TB infection–negative (LTBI(–)) HHCs for 2 years. Those who remained LTBI(–) throughout the study were identified as nonconverters. At baseline, nonconverters had a higher percentage of CD14(+) and CD3(–)CD56(+)CD27(+)CCR7(+) memory-like natural killer (NK) cells. Using a whole-transcriptome and metabolomic approach, we identified deoxycorticosterone acetate as a metabolite with elevated concentrations in the plasma of nonconverters, and further studies showed that this metabolite enhanced glycolytic ATP flux in macrophages and restricted M. tuberculosis growth by enhancing antimicrobial peptide production through the expression of the surface receptor sialic acid binding Ig-like lectin–14. Another metabolite, 4-hydroxypyridine, from the plasma of nonconverters significantly enhanced the expansion of memory-like NK cells. Our findings demonstrate that increased levels of specific metabolites can regulate innate resistance against M. tuberculosis infection in HHCs of patients with TB who never develop LTBI or active TB. |
format | Online Article Text |
id | pubmed-9746823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Clinical Investigation |
record_format | MEDLINE/PubMed |
spelling | pubmed-97468232022-12-15 Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection Tripathi, Deepak Devalraju, Kamakshi Prudhula Neela, Venkata Sanjeev Kumar Mukherjee, Tanmoy Paidipally, Padmaja Radhakrishnan, Rajesh Kumar Dozmorov, Igor Vankayalapati, Abhinav Ansari, Mohammad Soheb Mallidi, Varalakshmi Bogam, Anvesh Kumar Singh, Karan P. Samten, Buka Valluri, Vijaya Lakshmi Vankayalapati, Ramakrishna JCI Insight Research Article To determine the mechanisms that mediate resistance to Mycobacterium tuberculosis (M. tuberculosis) infection in household contacts (HHCs) of patients with tuberculosis (TB), we followed 452 latent TB infection–negative (LTBI(–)) HHCs for 2 years. Those who remained LTBI(–) throughout the study were identified as nonconverters. At baseline, nonconverters had a higher percentage of CD14(+) and CD3(–)CD56(+)CD27(+)CCR7(+) memory-like natural killer (NK) cells. Using a whole-transcriptome and metabolomic approach, we identified deoxycorticosterone acetate as a metabolite with elevated concentrations in the plasma of nonconverters, and further studies showed that this metabolite enhanced glycolytic ATP flux in macrophages and restricted M. tuberculosis growth by enhancing antimicrobial peptide production through the expression of the surface receptor sialic acid binding Ig-like lectin–14. Another metabolite, 4-hydroxypyridine, from the plasma of nonconverters significantly enhanced the expansion of memory-like NK cells. Our findings demonstrate that increased levels of specific metabolites can regulate innate resistance against M. tuberculosis infection in HHCs of patients with TB who never develop LTBI or active TB. American Society for Clinical Investigation 2022-11-22 /pmc/articles/PMC9746823/ /pubmed/36509283 http://dx.doi.org/10.1172/jci.insight.152357 Text en © 2022 Tripathi et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Tripathi, Deepak Devalraju, Kamakshi Prudhula Neela, Venkata Sanjeev Kumar Mukherjee, Tanmoy Paidipally, Padmaja Radhakrishnan, Rajesh Kumar Dozmorov, Igor Vankayalapati, Abhinav Ansari, Mohammad Soheb Mallidi, Varalakshmi Bogam, Anvesh Kumar Singh, Karan P. Samten, Buka Valluri, Vijaya Lakshmi Vankayalapati, Ramakrishna Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection |
title | Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection |
title_full | Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection |
title_fullStr | Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection |
title_full_unstemmed | Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection |
title_short | Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection |
title_sort | metabolites enhance innate resistance to human mycobacterium tuberculosis infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746823/ https://www.ncbi.nlm.nih.gov/pubmed/36509283 http://dx.doi.org/10.1172/jci.insight.152357 |
work_keys_str_mv | AT tripathideepak metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT devalrajukamakshiprudhula metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT neelavenkatasanjeevkumar metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT mukherjeetanmoy metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT paidipallypadmaja metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT radhakrishnanrajeshkumar metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT dozmorovigor metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT vankayalapatiabhinav metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT ansarimohammadsoheb metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT mallidivaralakshmi metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT bogamanveshkumar metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT singhkaranp metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT samtenbuka metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT vallurivijayalakshmi metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection AT vankayalapatiramakrishna metabolitesenhanceinnateresistancetohumanmycobacteriumtuberculosisinfection |